itraconazole has been researched along with Cytomegalovirus in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amat, P; Benet, I; Bravo, D; Clari, MÁ; Costa, E; Giménez, E; Muñoz-Cobo, B; Navarro, D; Nieto, J; Remigia, MJ; Solano, C | 1 |
Bouza, E; Desco, M; Domínguez, MJ; Muñoz, P; Palomo, J; Rodríguez, C; Yañez, JF | 1 |
2 other study(ies) available for itraconazole and Cytomegalovirus
Article | Year |
---|---|
An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Echinocandins; Female; Fluconazole; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Male; Middle Aged; Phosphoproteins; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Superinfection; Transplantation, Homologous; Triazoles; Viral Matrix Proteins; Voriconazole; Young Adult | 2014 |
Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Cytomegalovirus; Cytomegalovirus Infections; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Itraconazole; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Proportional Hazards Models; Regression Analysis; Risk; Risk Factors; Time Factors; Treatment Outcome | 2004 |